Skip to main content
Fig. 4 | Immunity & Ageing

Fig. 4

From: Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy

Fig. 4

Antigen presenting cells responses in young, old non-frail and old frail patients. PHA proliferation assays were performed to evaluate the patients’ lymphocytes proliferative potential. Statistical differences were assessed using Kruskal–Wallis tests and p < 0.05. Abbreviation: SI, stimulation index, IQR: interquartile range, SD: standard deviation

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us